[
  {
    "criterion": "Provides a specific recommended initial dose for carbamazepine in moderate hepatic impairment",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Mentions the importance of monitoring liver function and plasma drug levels when managing carbamazepine in moderate hepatic impairment",
    "axis": "completeness",
    "point": 6
  },
  {
    "criterion": "Incorrectly recommends a dose range that is too high or too low for carbamazepine in moderate hepatic impairment",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Fails to mention the importance of slower titration when managing carbamazepine in moderate hepatic impairment",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Provides clear and concise language to explain the recommended dose range for carbamazepine in moderate hepatic impairment",
    "axis": "communication_quality",
    "point": 7
  },
  {
    "criterion": "Mentions that the recommended dose range for carbamazepine in moderate hepatic impairment is based on clinical response and tolerance",
    "axis": "accuracy",
    "point": 5
  },
  {
    "criterion": "Incorrectly states that the recommended dose range for carbamazepine in moderate hepatic impairment is the same as for patients without liver impairment",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Fails to ask for clarification on the patient's lab results or response to treatment",
    "axis": "context_awareness",
    "point": -3
  },
  {
    "criterion": "Provides a clear explanation of the potential risks of carbamazepine in moderate hepatic impairment and the importance of close monitoring",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Mentions that the recommended dose range for carbamazepine in moderate hepatic impairment may need to be adjusted based on the patient's response to treatment",
    "axis": "completeness",
    "point": 6
  },
  {
    "criterion": "Incorrectly states that carbamazepine is not recommended for patients with moderate hepatic impairment",
    "axis": "accuracy",
    "point": -10
  }
]